Product image of Linezolid Stada (Linezolid) supplied by GNH India

Linezolid Stada

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Stada (Linezolid)

Linezolid, the active ingredient in Linezolid Stada, is an oxazolidinone presented as an injectable solution for intravenous use. It treats serious bacterial infections such as skin and soft tissue infections, community‑acquired and hospital‑acquired pneumonia, and infections caused by methicillin‑resistant Staphylococcus aureus (MRSA) in adult patients.

GNH India supplies Linezolid Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Manufacturer / TM Owner

Stadapharm Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is indicated for several serious bacterial infections affecting the respiratory and skin systems.

  • Skin and soft tissue infections: effective against susceptible Gram‑positive bacteria, reducing infection severity and promoting healing.
  • Community‑acquired pneumonia: helps eradicate causative pathogens, improving respiratory function and patient outcomes.
  • Hospital‑acquired (nosocomial) pneumonia: provides coverage for resistant organisms, aiding clinical recovery.
  • Ventilator‑associated pneumonia: offers activity against MRSA and other resistant strains in critically ill patients.
  • MRSA infections: delivers bacteriostatic activity against methicillin‑resistant Staphylococcus aureus, supporting infection control.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex. This blocks translation of essential proteins, producing a bacteriostatic effect against susceptible Gram‑positive organisms, including MRSA and VRE. By targeting a site distinct from other antibiotic classes, linezolid retains activity where other agents may fail.

Side Effects

Linezolid may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea
  • Diarrhea
  • Headache
  • Metallic taste

Serious or Rare Side Effects

  • Thrombocytopenia
  • Peripheral neuropathy
  • Serotonin syndrome
  • Optic neuropathy

Precautions & Warnings

When prescribing linezolid, clinicians should consider several precautionary measures to minimize risks.

  • Renal impairment: adjust therapy based on renal function and monitor for accumulation.
  • Hepatic impairment: monitor liver enzymes and consider dose modification if needed.
  • Concomitant serotonergic agents: avoid due to risk of serotonin syndrome.
  • Prolonged therapy: regularly assess complete blood count for thrombocytopenia or anemia.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Linezolid interacts with several medicines; awareness of the interaction level guides clinical management.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic drugs: risk of serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): increased serotonergic activity, contraindicated.
  • Rifampicin: induces metabolism, reducing linezolid plasma concentrations.
  • Tyramine‑rich foods: may precipitate hypertensive episodes when combined with linezolid.

Moderate Interactions (Monitor Closely)

  • Warfarin: may enhance anticoagulant effect, monitor INR.
  • NSAIDs: increased bleeding risk if thrombocytopenia develops.
  • Anticonvulsants such as carbamazepine: may affect blood counts and linezolid efficacy.

Frequently Asked Questions

Linezolid Stada is used to treat serious bacterial infections, including skin and soft tissue infections, community‑acquired pneumonia, hospital‑acquired pneumonia, and infections caused by methicillin‑resistant Staphylococcus aureus (MRSA). It is prescribed when an effective oxazolidinone antibiotic is required.

Linezolid works by binding to the bacterial 50S ribosomal subunit, blocking the formation of the initiation complex needed for protein synthesis. This inhibition stops the production of essential proteins, resulting in a bacteriostatic effect against susceptible Gram‑positive organisms.

The dose of Linezolid Stada is determined by the prescribing clinician based on the type and severity of the infection, patient weight, renal and hepatic function, and any concomitant medications. Exact dosing regimens are individualized and should follow the prescriber’s instructions.

Safety data for linezolid in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To order Linezolid Stada, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.

Linezolid offers oral and intravenous options with activity against MRSA, often used when vancomycin is unsuitable or resistance is suspected. Compared with vancomycin, linezolid provides better lung penetration and does not require therapeutic drug monitoring, but it may have a higher risk of hematologic side effects.

Linezolid Stada should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain stability and potency.

Linezolid Stada is supplied as an injectable solution for intravenous infusion. The infusion is typically administered over a period defined by the prescriber, often 30‑60 minutes, using aseptic technique and appropriate IV equipment.

Serious risks include thrombocytopenia, peripheral neuropathy, optic neuropathy, and serotonin syndrome, especially when combined with serotonergic agents. Patients should be monitored regularly for blood‑count changes, visual disturbances, and signs of serotonin excess.

Linezolid Stada should be avoided in patients with known hypersensitivity to linezolid or other oxazolidinones, those currently taking monoamine oxidase inhibitors, or individuals with uncontrolled hypertension who consume large amounts of tyramine‑rich foods.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT